Children

The safety and efficacy of maraviroc for paediatric use has not been studied in children younger than 16 years of age and it is not licensed for use in this age group. Clinical trials are being designed.

 

 

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.